Jiao Hong: Continue to do a good job in the review and approval of children's medication

Medical Network, July 27, July 26, Jiao Hong, director of the State Food and Drug Administration, led a team to the drug review center to work on site, focusing on the review and approval of children's drug use, investigating and understanding the current situation, researching and solving problems, and deploying the next stage Key work
.

Chen Shifei, a member of the Party Group and Deputy Director of the State Food and Drug Administration, carried out on-site office work.

The issue of child medication is a livelihood issue that the party and the state attach great importance to, and General Secretary Xi Jinping has issued important instructions on this issue many times
.

In order to thoroughly implement the spirit of the important instructions of General Secretary Jinping and the major decisions and deployments of the Party Central Committee and the State Council, and strive to solve the problem of "emergency and anxiety" among the people, the State Food and Drug Administration has continuously improved the accessibility and safety of medicines for children, and implemented it with practical actions.

Jiao Hong presided over the on-site office meeting, listened carefully to the reports on the acceptance and review of children’s medications, learned in detail about the relevant measures of the Center for Drug Evaluation to encourage and promote the development of children’s medications, and discussed in depth the challenges faced by the R&D and evaluation of children’s medications.
Withholding the requirements of the State Drug Administration’s learning history and implementing the "I do practical things for the masses" practical activity requirements, focusing on solving key and difficult problems in the research and development of children's drugs, launching a "combined boxing" that encourages R&D innovation, improves review efficiency, improves work >
.

Jiao Hong requested that we should continue to strengthen organization and leadership, maintain a good >
.

It is necessary to conduct in-depth investigations and research to understand urgent clinical needs and corporate R&D challenges, promote the strengthening of the coordination of production, education, research and application of children's drug use, and establish a sound coordination and cooperation mechanism

It is reported that encouraging and supporting the research and development of children's drugs is an important part of the practice activities of the State Drug Administration's Party Leadership Group to study the "I do practical things for the masses".
Supporting the research and development of strict supervision of children's drugs is one of the top ten projects of the State Drug Administration for the benefit of enterprises and the people.
"One
.

In 2020, the State Food and Drug Administration approved a total of 26 special medicines for children and increased medicines for children, an increase of 36.